Inform · Module 02
Pharmacogenomic decision-support, established once.
A patient’s lifetime pharmacogenomic profile across 100+ medications and 15+ drug classes — available at the point of every prescription.
Pharmacogenomic decision-support, established once, used every prescription.
100+ medications, 15+ drug classes
A pharmacogenomic profile covering high-impact medications across cardiology, oncology, psychiatry, anticoagulation, and pain management.
Right medication, right dose
Genotype-driven guidance on which medication and what dose, replacing trial-and-error prescribing with precision-medicine recommendations.
Actionable alternative-medication guidance
Where a patient’s genotype suggests reduced efficacy or elevated risk, alternative medications and dosage adjustments are surfaced at the point of care.
Adverse-event reduction
Pre-emptive PGx testing has been shown in published clinical literature to materially reduce adverse drug reactions across high-risk drug classes.
Adaptive updates
Recommendations refresh as new pharmacogenomic evidence is published, so a patient’s lifetime profile stays current without re-testing.
Reports for clinicians and patients
Clinician-grade variant interpretation paired with patient-facing summaries explaining what each finding means for medication choices.